EA201492091A1 - Фармацевтические композиции для местного применения, содержащие тербинафид и мочевину - Google Patents

Фармацевтические композиции для местного применения, содержащие тербинафид и мочевину

Info

Publication number
EA201492091A1
EA201492091A1 EA201492091A EA201492091A EA201492091A1 EA 201492091 A1 EA201492091 A1 EA 201492091A1 EA 201492091 A EA201492091 A EA 201492091A EA 201492091 A EA201492091 A EA 201492091A EA 201492091 A1 EA201492091 A1 EA 201492091A1
Authority
EA
Eurasian Patent Office
Prior art keywords
urea
terbinaphid
pharmaceutical compositions
local application
application containing
Prior art date
Application number
EA201492091A
Other languages
English (en)
Inventor
Дирк-Хайнрих Эферс
Забине Фильхауэр
Саша Гориссен
Михаэль Хербиг
Хеннинг Маллвитц
Кристоф Виллерс
Original Assignee
Альмиралль, С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46148606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201492091(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Альмиралль, С.А. filed Critical Альмиралль, С.А.
Publication of EA201492091A1 publication Critical patent/EA201492091A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к фармацевтической композиции для местного применения, содержащей в расчете на общую массу композиции: а) 1,5-5 мас.% тербинафина или любой его фармацевтически приемлемой соли; b) 15-35 мас.% мочевины и с) более 25 мас.% воды.
EA201492091A 2012-05-14 2013-05-13 Фармацевтические композиции для местного применения, содержащие тербинафид и мочевину EA201492091A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261646650P 2012-05-14 2012-05-14
EP20120003791 EP2664327A1 (en) 2012-05-14 2012-05-14 Topical pharmaceutical compositions comprising terbinafide and urea
PCT/EP2013/059814 WO2013171159A1 (en) 2012-05-14 2013-05-13 Topical pharmaceutical compositions comprising terbinafine and urea

Publications (1)

Publication Number Publication Date
EA201492091A1 true EA201492091A1 (ru) 2015-03-31

Family

ID=46148606

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201492091A EA201492091A1 (ru) 2012-05-14 2013-05-13 Фармацевтические композиции для местного применения, содержащие тербинафид и мочевину

Country Status (20)

Country Link
US (1) US20150111971A1 (ru)
EP (2) EP2664327A1 (ru)
JP (1) JP2015516455A (ru)
KR (1) KR20150013162A (ru)
CN (1) CN104302281A (ru)
AR (1) AR091039A1 (ru)
AU (1) AU2013261918A1 (ru)
BR (1) BR112014028280A2 (ru)
CA (1) CA2872210A1 (ru)
CL (1) CL2014003081A1 (ru)
CO (1) CO7131352A2 (ru)
EA (1) EA201492091A1 (ru)
HK (1) HK1202808A1 (ru)
IL (1) IL235241A0 (ru)
MX (1) MX2014013851A (ru)
PH (1) PH12014502512A1 (ru)
SG (1) SG11201407536UA (ru)
TW (1) TW201350107A (ru)
WO (1) WO2013171159A1 (ru)
ZA (1) ZA201407655B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201317005D0 (en) * 2013-09-25 2013-11-06 Blueberry Therapeutics Ltd Composition and methods of treatment
PL3209319T3 (pl) 2014-10-21 2021-12-20 Hexima Limited Sposób leczenia zakażeń grzybiczych
GB201605127D0 (en) * 2016-03-25 2016-05-11 Blueberry Therapeutics Ltd Composition and methods of treatment
EP3582768A4 (en) * 2017-02-15 2020-11-18 Botanix Pharmaceuticals Ltd CANNABINOID FORMULATIONS FOR THE TREATMENT OF DERMATITIS AND INFLAMMATORY SKIN DISEASES
EP3492068A1 (en) 2017-12-01 2019-06-05 NCP NewCare Products GmbH Composition for treating onychomycosis
WO2019214838A1 (en) * 2018-05-09 2019-11-14 Eviderm Institute Ab Use of an alcohol-containing composition for improving the skin barrier function
PL245223B1 (pl) * 2019-01-10 2024-06-03 Biotts Spolka Akcyjna Nośnik farmaceutyczny dla substancji czynnych oraz kompozycja farmaceutyczna go zawierająca
JP6591100B1 (ja) * 2019-01-25 2019-10-16 ロート製薬株式会社 爪及び爪周り用医薬組成物
WO2024038427A1 (en) * 2022-08-17 2024-02-22 Lyotropic Delivery Systems Ltd. Topical delivery of antifungal agents for treating fungal infections
KR102597564B1 (ko) * 2023-03-03 2023-11-03 장병모 조갑 및 피부 백선의 예방 또는 치료용 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
WO2011014850A2 (en) * 2009-07-31 2011-02-03 Nuvo Research Inc. Topical eutectic-based formulations
WO2011079234A2 (en) * 2009-12-23 2011-06-30 Nuvo Research Inc. Highly permeating terbinafine formulation

Also Published As

Publication number Publication date
PH12014502512A1 (en) 2014-12-22
CA2872210A1 (en) 2013-11-21
JP2015516455A (ja) 2015-06-11
US20150111971A1 (en) 2015-04-23
CN104302281A (zh) 2015-01-21
HK1202808A1 (en) 2015-10-09
ZA201407655B (en) 2015-06-24
BR112014028280A2 (pt) 2019-09-24
WO2013171159A1 (en) 2013-11-21
EP2664327A1 (en) 2013-11-20
AU2013261918A1 (en) 2014-11-06
IL235241A0 (en) 2014-12-31
AR091039A1 (es) 2014-12-30
SG11201407536UA (en) 2014-12-30
CL2014003081A1 (es) 2015-03-27
MX2014013851A (es) 2015-02-12
EP2849739A1 (en) 2015-03-25
TW201350107A (zh) 2013-12-16
KR20150013162A (ko) 2015-02-04
CO7131352A2 (es) 2014-12-01

Similar Documents

Publication Publication Date Title
EA201492091A1 (ru) Фармацевтические композиции для местного применения, содержащие тербинафид и мочевину
EA201600366A1 (ru) Производные бензимидазол-пролина
EA201891103A1 (ru) Композиции для лечения спинальной мышечной атрофии
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201492050A1 (ru) Модуляторы ядерного транспорта и их применение
EA201990388A1 (ru) Пиперидиновые модуляторы рецепторов cxcr7
EA201490037A1 (ru) Антагонисты trpv4
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
EA201400537A1 (ru) 18-МЕТИЛ-6,7-МЕТИЛЕН-3-ОКСО-17-ПРЕГН-4-ЕН-21,17β-КАРБОЛАКТОНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ СОЕДИНЕНИЯ, И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ ЭНДОМЕТРИОЗА
EA201492287A1 (ru) Дейтерированные производные руксолитиниба
EA201490471A1 (ru) Пиридазиноновые соединения и их применение в качестве ингибиторов daao
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
EA201201050A1 (ru) Пиразолы в качестве антагонистов crth2
EA201501163A1 (ru) Модуляторы рецептора cxcr7
EA201590475A1 (ru) Тетрациклиновые соединения
EA201490222A1 (ru) Комбинированные составы на основе дарунавира
EA201490223A1 (ru) Составы на основе дарунавира
EA201201109A1 (ru) Прасугрель в тонкоизмельченной кристаллической форме и фармацевтическая композиция, содержащая его
EA201600394A1 (ru) Трициклические соединения пиперидина
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
EA201590790A1 (ru) СТАБИЛЬНАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ PEG-ИНТЕРФЕРОНА АЛЬФА-2b
EA201490573A1 (ru) Соединение бензотиазолона
EA201591180A1 (ru) Составы ингибитора lfa-1
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.